稳心颗粒联合胺碘酮在冠心病心律失常治疗中的应用效果观察  

Application Effect observation of Wenxin Particle and Amiodarone in the Treatment of Coronary Heart Arrhythmia

作　　者：李丹丹[1] 朱志良[2] 

机构地区：[1]吉林省四平市第四人民医院,136000 [2]吉林省四平市中心人民医院,136000

出　　处：《中国继续医学教育》2016年第1期187-188,共2页China Continuing Medical Education

摘　　要：目的观察冠心病心律失常治疗中稳心颗粒＋胺碘酮的应用效果。方法收集2014年1月~2015年8月我院收治的112例冠心病心律失常患者为对象,将112例患者分为观察组（稳心颗粒＋胺碘酮治疗）与对照组（胺碘酮治疗）,对比两组病例治疗总有效率及不良反应。结果两组总有效率对比差异有统计学意义（P〈0.05）;且均无严重不良反应发生。结论冠心病心律失常治疗中稳心颗粒联合胺碘酮的应用效果显著。Objective To investigate application effect in the treatment of coronary heart with arrhythmia Wenxin particle ＋ amiodarone. Methods From January 2014 to August 2015 in our hospital,112 cases of coronary heart arrhythmia patients as objects,the 112 patients divided into two groups（Wenxin particle ＋ amiodarone therapy） and control group（amine iodine ketone therapy）,comparative analysis total efficiency of two groups of patients and adverse reactions. Results The total effective contrast significant difference（P〈0.05）,and there were no serious adverse events.Conclusion The effect of the treatment of coronary heart arrhythmia Wenxin particle combined with amiodarone significantly.

关 键 词：冠心病 心律失常 稳心颗粒 胺碘酮 

分 类 号：R541.7[医药卫生—心血管疾病]